Literature DB >> 16148971

Aspergillus mastoiditis in a patient with systemic lupus erythematosus: a case report.

Kwamena Amonoo-Kuofi1, Phillipa Tostevin, Jeff R Knight.   

Abstract

Fungal mastoiditis caused by Aspergillus fumigatus predominantly occurs in immunocompromised patients. Invasive temporal bone mycoses are rare. They are usually associated with host immunodeficiency, are difficult to diagnose, and many cases are fatal. Treatment consists of antifungal chemotherapy, surgical debridement, and attempts to control the underlying immunological condition. Published reports describe patients with previous ear pathology and associated facial nerve dysfunction. We report a case in a patient with systemic lupus erythematosus. A good outcome followed surgical debridement and the use of a new triazole antifungal agent, voriconazole. Our patient's facial nerve function was unaffected. The presence of normal facial nerve function, however, does not exclude the possibility of invasive fungal mastoiditis.

Entities:  

Year:  2005        PMID: 16148971      PMCID: PMC1150873          DOI: 10.1055/s-2005-870595

Source DB:  PubMed          Journal:  Skull Base        ISSN: 1531-5010


  15 in total

1.  PRIMARY ASPERGILLOSIS OF THE PARANASAL SINUSES AND ASSOCIATED AREAS.

Authors:  J F HORA
Journal:  Laryngoscope       Date:  1965-05       Impact factor: 3.325

2.  Invasive Aspergillus tympanomastoiditis in an immunocompetent patient.

Authors:  G E Bryce; P Phillips; M Lepawsky; M J Gribble
Journal:  J Otolaryngol       Date:  1997-08

3.  Fungal mastoiditis in the immunocompromised host.

Authors:  R J Stanley; T V McCaffrey; L H Weiland
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1988-02

Review 4.  Role of newer azoles in surgical patients.

Authors:  T F Patterson
Journal:  J Chemother       Date:  1999-12       Impact factor: 1.714

5.  Treatment of invasive aspergillosis with itraconazole.

Authors:  D W Denning; R M Tucker; L H Hanson; D A Stevens
Journal:  Am J Med       Date:  1989-06       Impact factor: 4.965

Review 6.  Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.

Authors:  Andrew J Ullmann
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

7.  Mycotic infection of the temporal bone.

Authors:  T J McGill
Journal:  Arch Otolaryngol       Date:  1978-03

Review 8.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 9.  Aspergillus sinusitis in patients with AIDS: report of three cases and review.

Authors:  W Teh; B S Matti; H Marisiddaiah; G Y Minamoto
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

Review 10.  [Voriconazole - applications and perspectives].

Authors:  M Ruhnke
Journal:  Mycoses       Date:  2002       Impact factor: 4.377

View more
  9 in total

Review 1.  Otogenic skull base osteomyelitis caused by invasive fungal infection. Case report and literature review.

Authors:  Dominik Stodulski; Bozena Kowalska; Czesław Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-09       Impact factor: 2.503

Review 2.  Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome.

Authors:  Maria N Gamaletsou; Blandine Rammaert; Marimelle A Bueno; Brad Moriyama; Nikolaos V Sipsas; Dimitrios P Kontoyiannis; Emmanuel Roilides; Valerie Zeller; Roberta Prinapori; Saad J Taj-Aldeen; Barry Brause; Olivier Lortholary; Thomas J Walsh
Journal:  J Infect       Date:  2013-12-27       Impact factor: 6.072

3.  Fulminant antiphospholipid antibody syndrome complicated by Aspergillus tracheobronchitis.

Authors:  Peralam Yegneswaran Prakash; Vinay Pandit; Sugandhi P Rao
Journal:  Med Mycol Case Rep       Date:  2012-10-22

4.  Fungal otomastoiditis: a case series in immunocompetent adults.

Authors:  Reena Varghese; Reshmi M Nair; Frankie Jose Kavalakkat
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-03-04

Review 5.  Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review.

Authors:  Maud Pichon; Véronique Joly; Nicolas Argy; Sandrine Houze; Stéphane Bretagne; Alexandre Alanio; Michel Wassef; Benjamin Verillaud; Yazdan Yazdanpanah
Journal:  Infection       Date:  2020-02-08       Impact factor: 3.553

Review 6.  Antifungal therapy of Aspergillus invasive otitis externa: efficacy of voriconazole and review.

Authors:  Perrine Parize; Marie-Olivia Chandesris; Fanny Lanternier; Sylvain Poirée; Jean-Paul Viard; Boris Bienvenu; Michaël Mimoun; Frédéric Méchai; Marie-France Mamzer; Philippe Herman; Marie-Elisabeth Bougnoux; Marc Lecuit; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

7.  The effects of caspofungin and voriconazole in an experimental fungal infection of the ear due to Aspergillus.

Authors:  Abdullah Ayçiçek; Zafer Cetinkaya; Halil Kiyici; Fethullah Kenar; Gülşah Aşik; Nuri Kiraz
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-04-02       Impact factor: 2.503

8.  Are systemic voriconazole and caspofungin ototoxic? An experimental study with rats.

Authors:  Emine Aydın; Filiz Aydoğan; Eren Taştan; Ayşe Iriz; Gökhan Karaca; Ilknur Haberal Can
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-08-27       Impact factor: 3.372

9.  Pseudomonas and Aspergillus interaction in malignant external otitis: risk of treatment failure.

Authors:  R Bovo; A Benatti; A Ciorba; M Libanore; M Borrelli; A Martini
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-12       Impact factor: 2.124

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.